Sanofi India Limited has informed the Exchange regarding Cessation of Mr Rodolfo Hrosz as Managing Director of the company w.e.f. April 30, 2025.
SANOFI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanofi India has informed the stock exchange that Mr. Rodolfo Hrosz will cease to be the Managing Director of the company with effect from April 30, 2025. No reason has been disclosed in this filing, and no successor has been announced. The Managing Director is the highest executive role in the company, equivalent to the CEO. This is a key managerial personnel change at the leadership level.
Investors should watch for a formal announcement regarding succession, as leadership transitions at the MD/CEO level can create short-term uncertainty around strategy and continuity. The stock may see mild volatility until a replacement is named.